Research - Santiago de Compostela, Galicia, Spain
LiberaBio is a preclinical stage biotech that develops new oncology treatments based on the proprietary MPN technology. This nanotechnology actively targets tumor and metastatic cells and delivers small and large molecules to on-surface or intracellular targets. The company is creating new treatments by delivering novel antibodies targeting intracellular oncoproteins.
reCAPTCHA
Outlook
Nginx
WordPress.org
Mobile Friendly